DOI: https://doi.org/10.22141/2224-0551.14.4.2019.174039

Atopic dermatitis is an important problem in current pediatrics

S.L. Nyankovskyy, O.S. Nyankovska, M.I. Horodylovska

Abstract


The article summarizes the data on atopic dermatitis problem in pediatric practice, in particular, the issues of its diagnosis and treatment are considered. Atopic dermatitis is the most common skin disease in children, which greatly reduces small patients quality of life. It is well known that this disease is the result of the complex interaction of defects in the barrier function of skin, immune dysregulation, and environmental and infectious agents. There are no specific diagnostic tests for atopic dermatitis. There is no pathognomonic laboratory biomarker for its diagnosis. One of the earliest and most recognized diagnostic criteria is the Hanifin and Rajka diagnostic criteria of 1980. The diagnosis is performed in the presence of three main criteria and three additional criteria. Approaches to its treatment and choice of effective and safe treatment method in childhood are particularly relevant in recent years. For children with atopic dermatitis, a differentiated, integrated approach to treatment is necessary. Successful treatment requires a multifaceted approach that involves teaching of the patient and care-takers, elimination diet in the event of a food allergy, optimal skin care, anti-inflammatory therapy with topical corticosteroids and/or topical calcineurin inhibitors, and treatment of skin infections. The main part of treatment is daily proper skin care. The use of moisturizers enhances the hydration of the skin. Emollients can reduce the inflammation and the severity of the disease. In addition, their use reduces the amount of anti-infectious agents to fight the disease.

Keywords


atopic dermatitis; diagnostic criteria; treatment; antihistamines; dimethindene maleate; infants

References


Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014 Jan;69(1):3-16. doi: 10.1111/all.12270.

Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):52. doi: 10.1186/s13223-018-0281-6.

Silverberg JI, Simpson EL. Associations of childhood eczema severity: a US population-based study. Dermatitis. 2014 May-Jun;25(3):107-14. doi: 10.1097/DER.0000000000000034.

Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018 Jun;73(6):1284-1293. doi: 10.1111/all.13401.

Hajar Т, Gontijo JV, Hanifin JM. New and developing therapies for atopic dermatitis. An Bras Dermatol. 2018 Jan-Feb;93(1):104-107. doi: 10.1590/abd1806-4841.20187682.

Egawa G, Kabashima K. Multifactorial skin barrier defіciency and atopic dermatitis: essential topics to prevent the atopic march. J Allergy Clin Immunol. 2016 Aug;138(2):350-358.e1. doi: 10.1016/j.jaci.2016.06.002.

Nomura T, Kabashima K. Advances in atopic dermatitis in 2015. J Allergy Clin Immunol. 2016 Dec;138(6):1548-1555. doi: 10.1016/j.jaci.2016.10.004.

HUGO Gene Nomenclature Commitee. Symbol report for FLG. HGNC:3748.

Reshetilo OV. Clinical course of atopic dermatitis in children with polymorphism (R501H), (2282del4) in filaggrin gene. Sovremennaya pediatriya. 2016;(77):75-77. doi10.15574/SP.2016.77.75.

Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004 Jan;75(1):39-48. doi: 10.1189/jlb.0403147.

Zaikov S. Atopic dermatitis in children. Dityachij likar. 2010;(4):51–58.

Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010.

Ministry of Health of Ukraine. Order 670 from July 04 2016, Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care: Atopic dermatitis. Available from: https://zakon.rada.gov.ua/rada/show/v0670282-16.

Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003 Dec;49(6):1088-95. doi: 10.1067/S0190.

Okhotnikova EN, Yakovleva NY. Atopic dermatitis in children: epidemiology, etiology, pathogenesis, clinic and diagnostics, Part 1. Lìki Ukraïni. 2018;(217):39-44.

Kim JS. Pediatric atopic dermatitis: the importance of food allergens. Semin Cutan Med Surg. 2008 Jun;27(2):156-60. doi: 10.1016/j.sder.2008.05.003.

Korotkiy NG, Tikhomirov AA, Taganov AV, Moiseenko AV. Atopicheskij dermatit u detej [Atopic dermatitis in children]. Ukraine, Tver: OOO «Izdatelstvo Triada; 2003. 238 p.

Hanifin JM, Chan SC. Diagnosis and treatment of atopic dermatitis. Dermatological Therapy. 1996;1:9-18.

Lee JH, Son SW, Cho SH. A comprehensive review of the treatment of atopic eczema. Allergy Asthma Immunol Res. 2016 May;8(3):181-90. doi: 10.4168/aair.2016.8.3.181.

Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016 Mar 12;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X.

Ministry of Health of Ukraine. Features of diagnostics and approaches to treatment-and-prophylactic nutrition of young children with allergies to cow's milk protein, Guidelines, Kiev, 2014. Dityachij likar. 2015;(38):3-48.

Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014 Jul;71(1):116-32. doi: 10.1016/j.jaad.2014.03.023.

Hon KL, Ching GK, Leung TF, Choi CY, Lee KK, Ng PC. Estimating emollient usage in patients with eczema. Clin Exp Dermatol. 2010 Jan;35(1):22-6. doi: 10.1111/j.1365-2230.2009.03341.x.

Umar M, Sastry KS, Al Ali F, Al-Khulaifi M, Wang E, Chouchane AI. Vitamin D and the Pathophysiology of Inflammatory Skin Diseases. Skin Pharmacol Physiol. 2018;31(2):74-86. doi: 10.1159/000485132.

Yentzer BA, Ade RA, Fountain JM, et al. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010 Oct;86(4):208-13.

Breuer K, Werfel T, Kapp A. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol. 2005;6(2):65-77. DOI: 10.2165/00128071-200506020-00001.

Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018 May;32(5):657-682. doi: 10.1111/jdv.14891.

Marushko YuV. Experience of use of «Fenistil» in the form of drops and gel in pediatric practice. Perinatologiya i pediatriya. 2013;(55):48-52.

Glushkova EF, Surovenko TN. Features of prescribing antihistamines in pediatric practice. Meditsinskiy sovet. 2017;(9):120-123. doi: 10.21518/2079-701X-2017-9-120-123.






Copyright (c) 2019 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта